Ocular Surface Squamous Neoplasia – Appropriate Approach Of Suspicious Lesions
Published 2022 - 40th Congress of the ESCRS
Reference: PP02.16 | Type: ESCRS 2022 - Posters | DOI: 10.82333/ngv1-9x87
Authors: Ana Rita Viana* 1 , Rita Basto 1 , Renato Barbosa 1 , Alexandre Silva 1 , Rita Gonçalves 1 , Pedro Coelho 2
1Ophthalmology Department,Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos,Matosinhos,Portugal, 2Ophthalmology Department,Centro Hospitalar do Tâmega e Sousa,Penafiel,Portugal
Purpose
Ocular surface squamous neoplasia (OSSN) describes a spectrum of slowly progressive epithelial lesions of the conjunctiva and cornea, mostly located at the limbus. The lesion may appear gelatinous, leukoplakic or papillomatous. Corneal involvement may present as a translucent epithelial sheet. Risk factors include ultraviolet light exposure, aging, smoking, immunosuppression, among others. Metastatic disease is rare. This case report aims to describe the clinical findings of two patients with suspicious conjunctival lesions, emphasizing the alarm signals and risk factors of OSSN, the appropriate clinical approach and different therapeutic options available.
Setting
The diagnosis and clinical approach of the reported cases took place at the Ophthalmology Department of Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Portugal.
Methods
Report of two cases of OSSN suspected lesions that were differently managed.
Results
An 87-year-old female presented an irregular fibrovascular lesion at the temporal limbus of her right eye showing corneal extension. The lesion was surgically excised with 4-mm margins and adjunctive cryotherapy. The corneal portion of the tumor was managed with absolute alcohol-assisted epithelial curettage. The histologic exam confirmed high grade conjunctival intraepithelial neoplasia. Six months later the tumor reappeared, and it was managed with topical chemotherapy.
The second case describes a 68-year-old female that presented a vascularized, salmon-colored perilimbal lesion in her right eye, with peripheral corneal invasion. This patient was primary treated with topical chemotherapy, demonstrating tumor regression.
Conclusions